Zurcher Kantonalbank (Zurich Cantonalbank) Immunity Bio, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 43,992 shares of IBRX stock, worth $109,980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,992
Previous 43,992
-0.0%
Holding current value
$109,980
Previous $132,000
12.12%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IBRX
# of Institutions
272Shares Held
120MCall Options Held
2.49MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$54.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$21.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19.4 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$19.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...